Form 4: PROCEPT BioRobotics Director Exercises Stock Options

PROCEPT BioRobotics Director Antal Rohit Desai exercised stock options to acquire 26,749 shares of common stock at $1.33 per share.

Summary

• Director Antal Rohit Desai of PROCEPT BioRobotics Corp (PRCT) exercised stock options on August 14, 2025, acquiring 26,749 shares of common stock.
• The exercise price for these shares was $1.33 per share.
• Following this transaction, Mr. Desai directly holds 35,152 shares of common stock.
• Additionally, Mr. Desai indirectly holds 14,363 shares of common stock through The 2:22 DNA Trust.
• The exercised options were fully vested and exercisable, with an expiration date of September 17, 2025.

Sentiment

Score: 7

Explanation: The exercise of stock options by a director is generally viewed as a positive signal of insider confidence in the company's future prospects, although it is often a pre-planned event rather than a discretionary purchase.

Positives

• Director Antal Rohit Desai increased his direct beneficial ownership in PROCEPT BioRobotics Corp by 26,749 shares, signaling confidence in the company's future.
• The exercise price of $1.33 per share is significantly lower than the implied market price at the time of exercise, indicating a potential gain for the director and a belief in the stock's value.

Future Outlook

No specific forward-looking statements or guidance were provided in this filing.

Industry Context

This filing details an insider transaction for PROCEPT BioRobotics, a company operating in the medical robotics sector. While not directly indicative of broader industry trends, it reflects an insider's view on the company's prospects within its specialized field.

Related Party Transactions

• Director Antal Rohit Desai's exercise of stock options is a related party transaction, as it involves a key management personnel acquiring shares from the company.

Stakeholder Impact

• Shareholders may interpret the director's increased ownership as a positive signal of confidence in the company's long-term value and performance.

Key Dates

Recommendation

While the director's exercise of stock options indicates confidence, a single insider transaction typically does not warrant a change in investment recommendation without further fundamental analysis of the company's financial performance, strategic outlook, and broader market conditions.

Keywords

PROCEPT BioRobotics, PRCT, Antal Rohit Desai, Form 4, insider transaction, stock option exercise, director, beneficial ownership